DE1280877B - Process for the preparation of 4-aminouracils substituted in the 1-position - Google Patents

Process for the preparation of 4-aminouracils substituted in the 1-position

Info

Publication number
DE1280877B
DE1280877B DER32692A DER0032692A DE1280877B DE 1280877 B DE1280877 B DE 1280877B DE R32692 A DER32692 A DE R32692A DE R0032692 A DER0032692 A DE R0032692A DE 1280877 B DE1280877 B DE 1280877B
Authority
DE
Germany
Prior art keywords
vol
substituted
aminouracils
methyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DER32692A
Other languages
German (de)
Inventor
Dr Kailash Gauri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robugen GmbH
Original Assignee
Robugen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robugen GmbH filed Critical Robugen GmbH
Priority to DER32692A priority Critical patent/DE1280877B/en
Publication of DE1280877B publication Critical patent/DE1280877B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

Verfahren zur Herstellung von in 1-Stellung substituierten 4-Aminouracilen Die Erfindung bezieht sich auf ein Verfahren zur Herstellung von in l-Stellung substituierten 4Aminouracilen der allgemeinen Formel in der R den Methyl- oder Athylrest bedeutet, das dadurch gekennzeichnet ist, daß in l-Stellung entsprechend substituierte 4-Chloruracile mit Benzylamin oder Phenylhydrazin in an sich bekannter Weise umgesetzt werden und die entstandenen. in l-Stellung entsprechend substituierten 4-Benzylamino- bzw.Process for the preparation of 4-aminouracils substituted in the 1-position The invention relates to a process for the preparation of 4-aminouracils substituted in the 1-position of the general formula in which R denotes the methyl or ethyl radical, which is characterized in that 4-chlorouracils correspondingly substituted in the l-position are reacted with benzylamine or phenylhydrazine in a manner known per se and the resulting. 4-benzylamino- or 4-benzylamino- or 4-benzylamino- or

4-Phenylhydrazinouracile mit Wasserstoff in Gegenwart von PalladiumTierkohle oder Raney-Nickel hydriert werden.4-phenylhydrazinouracils with hydrogen in the presence of palladium animal charcoal or Raney nickel can be hydrogenated.

Die Verfahrensprodukte dienen als Zwischenprodukte zur Herstellung von Purinen, Pteridinen und in der Therapie angewandten Pharmazeutika. The process products serve as intermediate products for production of purines, pteridines and pharmaceuticals used in therapy.

Von diesen beiden Vertretern der in l-Stellung substituierten 4-Aminouracile ist das l-Methyl-4-aminouracil bekannt (» Chemische Berichte«. Bd. 90. Of these two representatives of the 4-aminouracils substituted in the l-position l-methyl-4-aminouracil is known ("Chemical Reports". Vol. 90.

S. 2275 [1957]). Das bekannte Verfahren zur Herstellung dieser Verbindung verläuft über mehr Stufen und liefert geringere Ausbeuten. Das erfindungsgemäße Verfahren dagegen ist wesentlich einfacher und liefert gute Ausbeuten.P. 2275 [1957]). The known method of making this compound takes place over more stages and gives lower yields. The inventive Process, however, is much simpler and gives good yields.

Es war auf Grund des Standes der Technik nicht zu erwarten, daß die hydrogenolytische Abspaltung der oben angegebenen Substituenten der Aminogruppe ohne Hydrierung des Uracils selbst nach dem beanspruchten Verfahren möglich ist. Based on the state of the art, it was not to be expected that the hydrogenolytic cleavage of the abovementioned substituents of the amino group is possible without hydrogenation of the uracil itself by the claimed process.

Beispiel 1 a) I-Methyl-4-benzylaminouracil 1,6 g g 1-Methyl-4-chloruracil wurden mit 3,2 g Benzylamin in 10 ml Methylalkohol versetzt und 2 Stunden unter Rückfluß gekocht. Das Lösungsmittel und überschüssiges Amin wurden abdestilliert der Rückstand mit Wasser gewaschen und aus Dimethylformamid umkristallisiert. F. 295 C; Ausbeute: 1.65 g. b) l-Methyl-4-aminouracil 1 g des oben erhaltenen Produkts wurde in 100 ml absolutem Athanol in einer Schüttelente über Pal- ladium Tierkohle mit Wasserstoff bei 40"C hydriert. Nach 6 Stunden war die theoretische Menge Wasserstoff aufgenommen (1 Mol). Der Katalysator wurde abfiltriert und das Filtrat im Vakuum eingeengt. Der Rückstand wurde aus Wasser umkristallisiert, wobei farblose Kristalle von l-MethylXaminouracil erhalten wurden. F. 326 bis 327"C; Ausbeute: 0,48 g. Example 1 a) I-methyl-4-benzylaminouracil 1.6 g g of 1-methyl-4-chlorouracil were mixed with 3.2 g of benzylamine in 10 ml of methyl alcohol and 2 hours under Refluxed. The solvent and excess amine were distilled off the residue is washed with water and recrystallized from dimethylformamide. F. 295 C; Yield: 1.65 g. b) 1-methyl-4-aminouracil 1 g of the product obtained above was in 100 ml of absolute ethanol in a shaking duck over pal- ladium animal charcoal hydrogenated with hydrogen at 40 ° C. After 6 hours, the theoretical amount of hydrogen was added (1 mole). The catalyst was filtered off and the filtrate in vacuo constricted. The residue was recrystallized from water, giving colorless crystals from l-methylXaminouracil. M.p. 326 to 327 "C; Yield: 0.48 g.

Beispiel 2 a) I-Methyl-4-phenylhydrazinouracil 3,2 g l-Methyl-4-chloruracil wurden mit 10 ml absolutem Athanol und 4,5 5 g Phenylhydrazin 1/2 Stunde unter Rückfluß gekocht. Der Alkohol und das überschüssige Phenylhydrazin wurden im Vakuum abdestilliert. Der kristalline Rückstand wurde mit Wasser gewaschen und aus Dimethylformamid umkristallisiert. F. 227'C (unter Zersetzung); Ausbeute: 4,8 g. b) I-Methyl-4-aminouracil 0, 7 g des oben erhaltenen Produkts wurden in 25 ml verdünntem Ammoniak gelöst und in einer Schüttelente über Raney-Nickel mit Wasserstoff hydriert. Nach 6 Stunden war die Wasserstoffaufnahme beendet. Der Katalysator wurde abfiltriert und das Filtrat mit Essigsäure neutralisiert. Die ausgeschiedenen Kristalle wurden abgenutscht und einige Male mit Wasser gewaschen. F. 327 C (identisch mit dem nach Beispiel 1 erhaltenen Produkt); Ausbeute: 0,4 g. Example 2 a) I-methyl-4-phenylhydrazinouracil 3.2 g of l-methyl-4-chlorouracil were refluxed with 10 ml of absolute ethanol and 4.5 5 g of phenylhydrazine for 1/2 hour cooked. The alcohol and the excess phenylhydrazine were distilled off in vacuo. The crystalline residue was washed with water and recrystallized from dimethylformamide. F. 227'C (with decomposition); Yield: 4.8 g. b) I-methyl-4-aminouracil 0.7 g des product obtained above was dissolved in 25 ml of dilute ammonia and placed in a Shake duck hydrogenated over Raney nickel with hydrogen. After 6 hours it was End of hydrogen uptake. The catalyst was filtered off and the filtrate with Acetic acid neutralized. The precipitated crystals were suction filtered and some Washed times with water. F. 327 C (identical to that obtained in Example 1 Product); Yield: 0.4 g.

Beispiel 3 a) 1-Athyl-4-phenylhydrazinouracil 2 g 1-Sithyl-4-chloruracil wurden in 10 ml heißem Methanol gelöst und mit 3,5 g Phenylhydrazin versetzt. Die Reaktionslösung wurde 1 Stunde unter Rückfluß gekocht, und das Lösungsmittel sowie das überschüssige Phenylhydrazin wurden im Vakuum abdestilliert. Der Rückstand wurde mit Wasser gewaschen und aus Äthanol umkristallisiert, wobei weiße watteartige Nadeln erhalten wurden. F. 220"C (unter Zersetzung); Ausbeute: 1,5 g. b) 1 -Athyl-4aminouracil 1,3 g des vorstehend erhaltenen 1-Äthyl-4phenylhydrazinouracils wurden in 30 ml verdünntem Ammoniak gelöst und über Raney-Nickel mit Wasserstoff bei Zimmertemperatur hydriert. Nach 10 Stunden war die Wasserstoffaufnahme beendet. Der Katalysator wurde abfiltriert und das Filtrat im Vakuum auf dem Wasserbad eingeengt. Der Rückstand wurde mit Wasser gewaschen und aus Methanol-Dimethylformamid umkristallisiert. F. 290 bis 292"C; Ausbeute: 0,65 g (etwa 80010 der Theorie). c) 1 -Athylaminouracil Durch Reduktion von analog Beispiel 1 a) erhaltenem 1-Äthyl-4benzylaminouracil mit Palladium-Tierkohle wurde ebenfalls 1-Athyl-$aminouracil erhalten, das mit dem nach Beispiel 3 b) erhaltenen 1-Äthyl-4aminouracil identisch war. Example 3 a) 1-Ethyl-4-phenylhydrazinouracil 2 g of 1-sithyl-4-chloruracil were dissolved in 10 ml of hot methanol and mixed with 3.5 g of phenylhydrazine. the The reaction solution was refluxed for 1 hour, and the solvent as well the excess phenylhydrazine was distilled off in vacuo. The residue was washed with water and recrystallized from ethanol, leaving white cotton wool-like needles were obtained. M.p. 220 "C (with decomposition); Yield: 1.5 g. B) 1-ethyl-4aminouracil 1.3 g of the 1-ethyl-4phenylhydrazinouracil obtained above were in 30 ml Dissolved dilute ammonia and over Raney nickel with hydrogen at room temperature hydrogenated. The uptake of hydrogen had ceased after 10 hours. The catalyst was filtered off and the filtrate concentrated in vacuo on a water bath. The residue was washed with water and recrystallized from methanol-dimethylformamide. F. 290 to 292 "C; Yield: 0.65 g (about 80010 of theory). C) 1-Ethylaminouracil By reduction of 1-ethyl-4benzylaminouracil obtained analogously to Example 1 a) with Palladium animal charcoal was also obtained 1-ethyl- $ aminouracil, which with the after Example 3 b) 1-ethyl-4aminouracil obtained was identical.

Claims (1)

Patentanspruch : Verfahren zur Herstellung von in 1-Stellung substituierten 4-Aminouracilen der allgemeinen Formel in der R den Methyl- oder Athylrest bedeutet, dadurch gekennzeichnet, daß man in 1-Stellung entsprechend substituierte 4-Chloruracile mit Benzylamin oder Phenylhydrazin in an sich bekannter Weise umsetzt und die erhaltenen, in 1-Stellung entsprechend substituierten 4Benzylamino- bzw. 4-Phenylhydrazinouracile mit Wasserstoff in Gegenwart von Palladium Tierkohle oder Raney-Nickel hydriert.Claim: Process for the preparation of 4-aminouracils substituted in the 1-position of the general formula in which R denotes the methyl or ethyl radical, characterized in that 4-chlorouracils correspondingly substituted in the 1-position are reacted with benzylamine or phenylhydrazine in a manner known per se and the 4-benzylamino- or 4- Phenylhydrazinouracile hydrogenated with hydrogen in the presence of palladium, animal charcoal or Raney nickel. In Betracht gezogene Druckschriften: Britische Patentschrift Nr. 845 378; Liebigs Annalen der Chemie, Bd. 615, 1958, S. 52 bis 56; Bd. 638, 1960, S. 205 bis 212; Chemische Berichte, Bd. 90, 1957, 5. 2272 bis 2276; Helvetica Chimica Acta, Bd. 6, 1923, S. 865 bis 880 ; Bd. 26, 1943, S. 929 bis 943. Documents considered: British Patent No. 845,378; Liebigs Annalen der Chemie, Vol. 615, 1958, pp. 52 to 56; Vol. 638, 1960, Pp. 205 to 212; Chemical Reports, Vol. 90, 1957, pp. 2272-2276; Helvetica Chimica Acta, Vol. 6, 1923, pp. 865 to 880; Vol. 26, 1943, pp. 929 to 943.
DER32692A 1960-11-16 1960-11-16 Process for the preparation of 4-aminouracils substituted in the 1-position Pending DE1280877B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DER32692A DE1280877B (en) 1960-11-16 1960-11-16 Process for the preparation of 4-aminouracils substituted in the 1-position

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DER32692A DE1280877B (en) 1960-11-16 1960-11-16 Process for the preparation of 4-aminouracils substituted in the 1-position

Publications (1)

Publication Number Publication Date
DE1280877B true DE1280877B (en) 1968-10-24

Family

ID=7403881

Family Applications (1)

Application Number Title Priority Date Filing Date
DER32692A Pending DE1280877B (en) 1960-11-16 1960-11-16 Process for the preparation of 4-aminouracils substituted in the 1-position

Country Status (1)

Country Link
DE (1) DE1280877B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140378491A1 (en) * 2013-06-21 2014-12-25 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
US9181200B2 (en) 2013-06-21 2015-11-10 MyoKardia, Inc. Pyrimidinedione compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845378A (en) * 1958-01-06 1960-08-24 Ici Ltd New pyrimidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845378A (en) * 1958-01-06 1960-08-24 Ici Ltd New pyrimidines

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140378491A1 (en) * 2013-06-21 2014-12-25 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
US9181200B2 (en) 2013-06-21 2015-11-10 MyoKardia, Inc. Pyrimidinedione compounds
US9199945B2 (en) 2013-06-21 2015-12-01 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
US9585883B2 (en) 2013-06-21 2017-03-07 MyoKardia, Inc. Pyrimidinedione compounds

Similar Documents

Publication Publication Date Title
DD148051A5 (en) PROCESS FOR PREPARING NEW INTERMEDIATE PRODUCTS FOR THE PREPARATION OF PHARMACEUTICALLY USEFUL COMPOUNDS
DE2012138C3 (en) N {4- (β-pyrazine-2-carboxyamido-ethyl) benzenesulphonyl] -N '- cycloalkylureas and pharmaceutical preparations containing them
DE1135915B (en) Process for the production of new, anticonvulsant spirohydantoins
DE1445186B2 (en) 3,3'-di-2-imidazolin-2-yl-carbanilide
DE2237632A1 (en) METHOD FOR PREPARING 1- (4-METHYL-6-METHOXY-2-PYRIMIDINYL) -3-METHYL-5METHOXYPYRAZOLE
DE1280877B (en) Process for the preparation of 4-aminouracils substituted in the 1-position
DE1670168C3 (en) 2-Benzenesulfonamido-4-methyl-5alkyl-pyrimidines and process for their preparation
EP0001760B1 (en) Alpha-aminomethylene-beta-formylaminopropionitrile, process for its preparation and its use in the preparation of 2-methyl-4-amino-5-formylaminomethylpyrimidine
DE671787C (en) Process for the preparation of pyrimidine compounds
AT164510B (en) Process for the preparation of p-aminobenzenesulfonamidopyrimidines
DE1695664A1 (en) Process for the preparation of substituted 4-aminouracils
DE921149C (en) Process for the preparation of d, l-dihydro-nor-lysergylglycine amide
EP0123035A1 (en) 4-Amino-3-imidozolin-2-on and (2-methoxy-2-imino-ethyl) urea, their preparation and application
DE932673C (en) Process for the preparation of alkylated dioxotetrahydropyridines
DE2409195B2 (en) PROCESS FOR PRODUCING IMIDAZOLE-4,5-DICARBOXAMIDE
DE945510C (en) Process for the preparation of 5,5-dipyridyl- (2 ') - hydantoins
DE737931C (en) Process for the preparation of 2,4-diaminochinazoline
DE874916C (en) Process for the preparation of diastereomeric N-substituted 1, 3-diphenyl-3-amino-propanolen- (1)
DE889151C (en) Process for the preparation of 2,4-diamino-5-phenyl-pyrimidine-Abkoemmlingen
DE846399C (en) Process for the production of amines
DE967642C (en) Process for the production of basic substituted butyric acid anilides
DE1570034A1 (en) Process for the production of nicotinic acid amides
DE2103134C3 (en) 2-Aminoindazolo [1,2-b] phthalazine-6- (11H), 13-dione, process for its preparation and pharmaceuticals containing it
DE2757586A1 (en) Sodium formyl-cyanamide, used as heterocycle intermediate - prepd. from sodium hydrogen cyanamide and formate ester
DE1134388B (en) Process for the preparation of 2-methyl-6-hydrazinoheptane